about
Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in ratsLPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice.Use of extracorporeal life support in adults with severe acute respiratory failure.Structure-function correlations of pulmonary surfactant protein SP-B and the saposin-like family of proteins.The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels.Surfactant protein D deficiency increases lung injury during endotoxemiaHigh-throughput evaluation of pulmonary surfactant adsorption and surface film formation
P2860
Q33414437-CB48B5F9-117E-42F3-B25A-34261D496AFFQ33815707-9DC2B249-E984-4E1B-A453-A5E32008F6A5Q37940006-51D7F4E3-1861-45A8-8A5D-61635A801BE3Q38045186-6F7CDA3A-2350-4AD1-BCBE-7E4EAA7A8E3BQ39192476-565B08B6-5EFC-42CC-A52A-6FA3E653C645Q41850339-5EB8A745-827F-465C-B28B-CB5D0010833FQ58831459-A0182073-0691-42C6-A0B0-F8F7B0567C5E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Exogenous surfactant therapy for ARDS.
@ast
Exogenous surfactant therapy for ARDS.
@en
type
label
Exogenous surfactant therapy for ARDS.
@ast
Exogenous surfactant therapy for ARDS.
@en
prefLabel
Exogenous surfactant therapy for ARDS.
@ast
Exogenous surfactant therapy for ARDS.
@en
P2860
P356
P1476
Exogenous surfactant therapy for ARDS.
@en
P2093
Adam Maruscak
Jim F Lewis
P2860
P356
10.1517/13543784.15.1.47
P407
P577
2006-01-01T00:00:00Z